P2RX1 and leukemia: An in vivo transplantation assay showed that the recipient mice receiving P2X1-knockdown THP-1 cells had reduced leukemia cell frequencies in the peripheral blood (Fig. S6G) and prolonged overall survival (24 or 38 days vs. 15 days, Fig. S6H) compared to control mice.